Tae Nyoung Chung is a biomedical researcher specializing in the pathophysiology of sepsis with a particular focus on mitochondrial function, immune modulation, and translational therapeutic strategies. His work integrates preclinical animal models, molecular biology, and translational insights to better understand and intervene in the systemic dysregulation that characterizes sepsis. Dr. Chung’s recent research has been published in internationally recognized journals and covers several key themes in sepsis biology. He has contributed to studies exploring mitochondrial transplantation as a novel therapeutic approach in sepsis models, demonstrating that the origin of transplanted mitochondria influences both cellular function and survival outcomes in polymicrobial sepsis. This research highlights the potential of targeting mitochondrial dysfunction to modulate oxidative phosphorylation and immune responses in critical illness. PubMed In addition to mitochondrial strategies, Dr. Chung has investigated immune responses in sepsis, including the dynamics of endotoxin tolerance — a form of immune suppression induced by repeated endotoxin exposure in sepsis. His co-authored studies have characterized serial changes in endotoxin tolerance in rat polymicrobial sepsis models, revealing how immune suppression evolves over time and correlates with inflammatory and metabolic markers. PubMed Dr. Chung’s research portfolio also includes studies on inflammatory signaling pathways and th